seed
Stage
3
Investors
About
T-Cypher Bio is a UK-based biotechnology company focused on developing novel T-cell receptor (TCR) based immunotherapies for cancer. They aim to create a pipeline of these advanced therapies to target various cancers.
Explore T-Cypher Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.